These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7865340)

  • 1. Suitability of Trinidad/Tobago as a potential site for phase III efficacy studies of HIV-1 vaccines.
    Paul R; Cleghorn F; Jack N; Edwards J; Mahabir B; Murphy J; Blattner W; Bartholomew C
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S9. PubMed ID: 7865340
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparations for AIDS vaccine evaluations. Progress in international cohort development and evaluation.
    Fischer RD; McNeil JG
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S223-5. PubMed ID: 7865306
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.
    Graham BS; Mascola JR
    J Infect Dis; 2005 Mar; 191(5):647-9. PubMed ID: 15688276
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VRX-496(VIRxSYS).
    Morris KV
    Curr Opin Investig Drugs; 2005 Feb; 6(2):209-15. PubMed ID: 15751745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building and testing an effective HIV vaccine.
    Kahn J
    West J Med; 1999; 171(5-6):363-5. PubMed ID: 10639877
    [No Abstract]   [Full Text] [Related]  

  • 7. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
    Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
    [No Abstract]   [Full Text] [Related]  

  • 8. Outstanding questions on HIV vaccine trial.
    Jefferys R; Harrington M
    Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
    [No Abstract]   [Full Text] [Related]  

  • 9. Support for the RV144 HIV vaccine trial.
    AIDS Vaccine Advocacy Coalition
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
    [No Abstract]   [Full Text] [Related]  

  • 10. Support for the RV144 HIV vaccine trial.
    Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
    [No Abstract]   [Full Text] [Related]  

  • 11. Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials.
    Francis DP; Heyward WL; Popovic V; Orozco-Cronin P; Orelind K; Gee C; Hirsch A; Ippolito T; Luck A; Longhi M; Gulati V; Winslow N; Gurwith M; Sinangil F; Berman PW
    AIDS; 2003 Jan; 17(2):147-56. PubMed ID: 12545073
    [No Abstract]   [Full Text] [Related]  

  • 12. Measuring HIV vaccine efficacy.
    Hernández-Suárez CM
    Stat Med; 2005 Apr; 24(7):983-92. PubMed ID: 15568204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.
    Rerks-Ngarm S; Brown AE; Khamboonruang C; Thongcharoen P; Kunasol P
    AIDS; 2006 Jul; 20(11):1471-9. PubMed ID: 16847401
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV vaccine trial results are an important step forward in developing an effective vaccine, say WHO and UNAIDS.
    Rassool GH
    J Adv Nurs; 2003 Jul; 43(2):116. PubMed ID: 12886893
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversial HIV vaccine enters phase III trials amid skepticism.
    AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccines under study.
    Ravanfar P; Mendoza N; Satyaprakash A; Jordan BI
    Dermatol Ther; 2009; 22(2):158-67. PubMed ID: 19335727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D; Elizaga M; Duerr A
    Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the future of HIV vaccines.
    Nabel GJ
    Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457
    [No Abstract]   [Full Text] [Related]  

  • 19. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
    Sheppard N; Sattentau Q
    Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV vaccine research in Thailand: lessons learned.
    Pitisuttithum P
    Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.